TCS8: PariS -TBI Study: Paris Severe Traumatic Brain Injury Study - 8 Years

Sponsor
Assistance Publique - Hôpitaux de Paris (Other)
Overall Status
Unknown status
CT.gov ID
NCT02050633
Collaborator
(none)
130
1
40
3.3

Study Details

Study Description

Brief Summary

The objective of the protocol is to pursue the long-term follow-up of a large cohort of severe traumatic brain injury patients. This outcome is to be described in terms of activity, participation, quality of life, socio-professional outcome, economical consequences and impact on caregivers, and in relation to health care provision.

Secondary objectives are to measure the impact on outcome of several predictive factors; to evaluate evolution of patients since the last (four-year) evaluation.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    This work represents a part of a larger collaborative prospective study called PariS-TBI (Severe Traumatic Brain Injury in the Parisian area) financed by the French National Authority for Health. The Paris-TBI study was undertaken in 2004, to provide epidemiological data. Patients aged 15 or more were included if they had sustained a severe TBI in the Parisian area during a 20-months period (2005-2007), defined by an initial Coma Glasgow Score (GCS) of 8 or less. Data from patients' demographics, injury characteristics, acute and post acute phase were collected prospectively. A total of 504 patients were included, of which 257 were alive at the time of this study. Patients (n = 134) were evaluated through a phone interview at one year post traumatism, and had a face-to-face evaluation at four years post-injury (n = 147).

    Investigations of the present work will be undertaken at eight years after the injury. Patients of the initial cohort will be contacted through post and phone call. Information about this follow up study will be given orally and through written form. Informed consent of patient or legal advisor will be obtained before setting an appointment for the evaluation.

    Evaluation will take place either in the patient's place of living, or in a clinical setting in the hospitals Broussais, Paris, France or Raymond Poincaré, Garches, France, according to the patient's choice.

    A trained neuropsychologist will lead the evaluations, during an interview with the patient and the informal caregiver, defined as the person (family member or friend), most responsible for day-to-day decision making and care for the patient. If a patient cannot attend the interview, a short questionnaire will be proposed to him by the neuropsychologist by phone.

    Demographic and pre-traumatism clinical data will be available from the initial study, as well as data on type and severity of traumatism, and on evolution during acute care. Data from the one-year and the four-year assessments will be available.

    Data assessed through the present study will include an evaluation of deficiencies: presence of somatic deficiencies, mood difficulties (Hospital Anxiety and Depression Score), cognitive deficiencies (Dysexecutive Questionnaire, questionnaire of complaints, filled in both by the patient himself and by his proxy). Neuropsychological testing will include the California Verbal Learning Test, Trail Making Test, the WAIS-IV Processing Speed Index, and the 6-Elements Test.

    Activities will be evaluated by the Glasgow Outcome Scale-Extended, and specifically through questions addressing driving ability, and ability to perform instrumental activities.

    Professional activity and change, and quality of life at work will be assessed through a standardized questionnaire.

    Data on patients' clinical care and services will be collected, including medical care, therapies, home assistance, socio-vocational assistance. Unmet need of services and barriers to care access will be assessed through a standardized questionnaire.

    Data on the quality of life of the informal caregiver and an evaluation of the burden of care will be collected, using the ZARIT questionnaire. Data on economical consequences of the injury on the patient, and on his care provider will be collected.

    The exploitation of this large database will enable an up-to-date description of the long term outcomes of severe TBI patients in the Parisian area. It will be used to clarify the role of several factors on long term activities and participations and on informal care burden.

    The comparison with the previous evaluations will allow evaluation of late evolution and of its determinants.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    130 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Eight-year Outcome and Health Care After Severe Traumatic Brain Injury in the Parisian Area
    Actual Study Start Date :
    Dec 1, 2014
    Anticipated Primary Completion Date :
    Dec 1, 2017
    Anticipated Study Completion Date :
    Apr 1, 2018

    Arms and Interventions

    Arm Intervention/Treatment
    Severe cranial trauma

    This is a cohort of adult patients who have suffered a severe TBI between 1 July 2005 and 1 May 2007.

    Outcome Measures

    Primary Outcome Measures

    1. Glasgow Outcome Scale-Extended [Eight years post-injury (one unique all-including evaluation)]

      This scale is assessed by a structured interview about the difficulties the patient in simple or elaborate acts of daily life

    Secondary Outcome Measures

    1. Neuropsychological testing: memory (California Verbal Learning Test), executive functioning (6-Elements Test, Dysexecutive Questionnaire by patient and caregiver), speed index (Trail Making Test, WAIS-IV Processing Speed Index). [Eight years post-injury (one unique all-including evaluation)]

    2. TBI-related complaints, by patient and caregiver [Eight years post-injury (one unique all-including evaluation)]

    3. Capacity of motor vehicle driving, independence in daily living activities [Eight years post-injury (one unique all-including evaluation)]

    4. Socio-professional integration [Eight years post-injury (one unique all-including evaluation)]

    5. Hospital Anxiety and Depression [Eight years post-injury (one unique all-including evaluation)]

    6. Patient's quality of life (0-10 numeric scale, by patient and caregiver) [Eight years post-injury (one unique all-including evaluation)]

    7. Quality of life of caregiver [Eight years post-injury (one unique all-including evaluation)]

    8. Caregiver burden (ZARIT questionnaire) [Eight years post-injury (one unique all-including evaluation)]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    15 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No

    Inclusion Criteria: all patients initially included in the Paris-TBI cohort, alive at time of evaluation. i.e.

    • Adults

    • Severe TBI with a Glasgow Coma Scale (GCS) score of 8 or less before admission to the hospital

    • Accident within the Regional Parisian area (Paris and 7 surrounding districts)

    Exclusion Criteria:
    • Refusal to participate

    • Impossibility to contact the person

    • Current living place outside the Parisian area

    • Impossibility to answer the questionnaire, in the absence of a proxy to assist

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 CRFTC Paris France 75014

    Sponsors and Collaborators

    • Assistance Publique - Hôpitaux de Paris

    Investigators

    • Principal Investigator: Claire CJ Jourdain, MD, Physical Medicine and Rehabilitation, Raymond Poincaré Hospital, 92380 Garches, France

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Assistance Publique - Hôpitaux de Paris
    ClinicalTrials.gov Identifier:
    NCT02050633
    Other Study ID Numbers:
    • 2013-A00881-44
    First Posted:
    Jan 31, 2014
    Last Update Posted:
    Nov 20, 2017
    Last Verified:
    Nov 1, 2017

    Study Results

    No Results Posted as of Nov 20, 2017